155 related articles for article (PubMed ID: 7493907)
21. Clinical and molecular characterization of Brazilian families with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation.
Gomy I; Molfetta GA; de Andrade Barreto E; Ferreira CA; Zanette DL; Casali-da-Rocha JC; Silva WA
Fam Cancer; 2010 Dec; 9(4):635-42. PubMed ID: 20567917
[TBL] [Abstract][Full Text] [Related]
22. VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation.
Brauch H; Weirich G; Brieger J; Glavac D; Rödl H; Eichinger M; Feurer M; Weidt E; Puranakanitstha C; Neuhaus C; Pomer S; Brenner W; Schirmacher P; Störkel S; Rotter M; Masera A; Gugeler N; Decker HJ
Cancer Res; 2000 Apr; 60(7):1942-8. PubMed ID: 10766184
[TBL] [Abstract][Full Text] [Related]
23. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
Lubensky IA; Gnarra JR; Bertheau P; Walther MM; Linehan WM; Zhuang Z
Am J Pathol; 1996 Dec; 149(6):2089-94. PubMed ID: 8952541
[TBL] [Abstract][Full Text] [Related]
24. [Frequent somatic mutations of the von Hippel-Lindau tumor suppressor gene in primary sporadic human renal clear cell carcinomas].
Gong K; Zhang Z; Xin D
Zhonghua Yi Xue Za Zhi; 2001 Feb; 81(3):142-4. PubMed ID: 11798864
[TBL] [Abstract][Full Text] [Related]
25. von Hippel-Lindau disease gene deletion detected in microdissected sporadic human colon carcinoma specimens.
Zhuang Z; Emmert-Buck MR; Roth MJ; Gnarra J; Linehan WM; Liotta LA; Lubensky IA
Hum Pathol; 1996 Feb; 27(2):152-6. PubMed ID: 8617456
[TBL] [Abstract][Full Text] [Related]
26. Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma.
Foster K; Prowse A; van den Berg A; Fleming S; Hulsbeek MM; Crossey PA; Richards FM; Cairns P; Affara NA; Ferguson-Smith MA
Hum Mol Genet; 1994 Dec; 3(12):2169-73. PubMed ID: 7881415
[TBL] [Abstract][Full Text] [Related]
27. Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions.
Gallou C; Chauveau D; Richard S; Joly D; Giraud S; Olschwang S; Martin N; Saquet C; Chrétien Y; Méjean A; Correas JM; Benoît G; Colombeau P; Grünfeld JP; Junien C; Béroud C
Hum Mutat; 2004 Sep; 24(3):215-24. PubMed ID: 15300849
[TBL] [Abstract][Full Text] [Related]
28. Biallelic inactivation of the von Hippel-Lindau tumor suppressor gene in sporadic renal cell carcinoma.
Hamano K; Esumi M; Igarashi H; Chino K; Mochida J; ISHIDA And H; Okada K
J Urol; 2002 Feb; 167(2 Pt 1):713-7. PubMed ID: 11792959
[TBL] [Abstract][Full Text] [Related]
29. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
[TBL] [Abstract][Full Text] [Related]
30. The von Hippel-Lindau tumor suppressor gene and kidney cancer.
Kaelin WG
Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6290S-5S. PubMed ID: 15448019
[TBL] [Abstract][Full Text] [Related]
31. Renal cell carcinomas in trichloroethene (TRI) exposed persons are associated with somatic mutations in the von Hippel-Lindau (VHL) tumour suppressor gene.
Brüning T; Weirich G; Hornauer MA; Höfler H; Brauch H
Arch Toxicol; 1997; 71(5):332-5. PubMed ID: 9137812
[TBL] [Abstract][Full Text] [Related]
32. Mutational state of von Hippel-Lindau and adenomatous polyposis coli genes in renal tumors.
Suzuki H; Ueda T; Komiya A; Okano T; Isaka S; Shimazaki J; Ito H
Oncology; 1997; 54(3):252-7. PubMed ID: 9143408
[TBL] [Abstract][Full Text] [Related]
33. Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC.
Gallou C; Joly D; Méjean A; Staroz F; Martin N; Tarlet G; Orfanelli MT; Bouvier R; Droz D; Chrétien Y; Maréchal JM; Richard S; Junien C; Béroud C
Hum Mutat; 1999; 13(6):464-75. PubMed ID: 10408776
[TBL] [Abstract][Full Text] [Related]
34. Transcription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel-Lindau tumor suppressor protein.
Lee S; Neumann M; Stearman R; Stauber R; Pause A; Pavlakis GN; Klausner RD
Mol Cell Biol; 1999 Feb; 19(2):1486-97. PubMed ID: 9891082
[TBL] [Abstract][Full Text] [Related]
35. Identification of somatic mutations in the von Hippel-Lindau (VHL) gene in a patient with renal cell carcinoma.
Wang WC; Chen HJ; Tseng YH; Lai YC
J Formos Med Assoc; 2009 Nov; 108(11):886-93. PubMed ID: 19933033
[TBL] [Abstract][Full Text] [Related]
36. VHL gene alterations in Italian patients with isolated renal cell carcinomas.
Muscarella LA; D'Agruma L; la Torre A; Gigante M; Coco M; Parrella P; Battaglia M; Carrieri G; Carella M; Zelante L; Fazio VM; Gesualdo L; Ranieri E
Int J Biol Markers; 2013 Jun; 28(2):208-15. PubMed ID: 23558940
[TBL] [Abstract][Full Text] [Related]
37. Intragenic Tsc2 somatic mutations as Knudson's second hit in spontaneous and chemically induced renal carcinomas in the Eker rat model.
Kobayashi T; Urakami S; Hirayama Y; Yamamoto T; Nishizawa M; Takahara T; Kubo Y; Hino O
Jpn J Cancer Res; 1997 Mar; 88(3):254-61. PubMed ID: 9140109
[TBL] [Abstract][Full Text] [Related]
38. Integrative analysis of dysregulated microRNAs and mRNAs in multiple recurrent synchronized renal tumors from patients with von Hippel-Lindau disease.
Gattolliat CH; Couvé S; Meurice G; Oréar C; Droin N; Chiquet M; Ferlicot S; Verkarre V; Vasiliu V; Molinié V; Méjean A; Dessen P; Giraud S; Bressac-De-Paillerets B; Gardie B; Tean Teh B; Richard S; Gad S
Int J Oncol; 2018 Oct; 53(4):1455-1468. PubMed ID: 30066860
[TBL] [Abstract][Full Text] [Related]
39. Suppression of growth of renal carcinoma cells by the von Hippel-Lindau tumor suppressor gene.
Chen F; Kishida T; Duh FM; Renbaum P; Orcutt ML; Schmidt L; Zbar B
Cancer Res; 1995 Nov; 55(21):4804-7. PubMed ID: 7585510
[TBL] [Abstract][Full Text] [Related]
40. Mutations of the VHL tumour suppressor gene in renal carcinoma.
Gnarra JR; Tory K; Weng Y; Schmidt L; Wei MH; Li H; Latif F; Liu S; Chen F; Duh FM
Nat Genet; 1994 May; 7(1):85-90. PubMed ID: 7915601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
